Atnaujinkite slapukų nuostatas

El. knyga: Esophagus

Associate editor , Edited by (Hahnemann University, USA), Associate editor , Associate editor , Associate editor , Associate editor , Edited by (University of South Florida, USA)
  • Formatas: EPUB+DRM
  • Išleidimo metai: 06-May-2021
  • Leidėjas: Wiley-Blackwell
  • Kalba: eng
  • ISBN-13: 9781119599678
Kitos knygos pagal šią temą:
  • Formatas: EPUB+DRM
  • Išleidimo metai: 06-May-2021
  • Leidėjas: Wiley-Blackwell
  • Kalba: eng
  • ISBN-13: 9781119599678
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

THE ESOPHAGUS The Esophagus investigates the anatomy, physiology, and pathology of the esophagus. This sixth edition, revised and updated throughout, also explores the diagnosis and treatment of various esophageal conditions. It includes treatment guidelines approved by the two largest gastroenterology societies, the ACG and AGA, as befits a work co-edited by two former presidents of those organizations. Advancements in diagnostics are presented, as are developments in the surgical and drug therapies.

Presented in full colour, and boasting an unrivalled team of editors and contributing authors, The Esophagus Sixth Edition will find a home wherever the anatomy, physiology, and pathology of the esophagus are studied and taught.

This book is accompanied by a website containing all the figures from the book in PowerPoint format.

www.wiley.com/go/richter/esophagus6e

Praise for the Fifth Edition:

There is absolutely no doubt that this edition of the textbook will maintain its status as the go-to reference for esophageal conditions, and will remain a highly utilized and clinically useful resource for novice and experienced physicians and surgeons alike. (Gastroenterology, 1 July 2013)
Contributors xxxiii
Preface: The History of Esophagology xxxvii
Donald O. Castell
About the Companion Website xxxviii
Part I Esophageal Symptoms 1(58)
1 Symptom Overview and Quality of Life
3(15)
John W. Jacobs Jr
Introduction
3(1)
Esophageal anatomy and production of symptoms
3(1)
Anatomy
3(1)
Esophageal muscle and sphincters
4(1)
Development of esophageal symptoms
4(1)
Symptoms
4(6)
Dysphagia
5(1)
Patient history and physical examination
6(1)
Esophageal dysphagia
6(1)
Diagnostic approach
6(1)
Odynophagia
7(1)
Heartburn and regurgitation
8(1)
Chest Pain
8(1)
Globus
9(1)
GERD and extraesophageal symptoms
9(1)
Healthcare utilization and quality of life
10(3)
Symptom and quality of life assessment tools
10(3)
Conclusion
13(1)
References
13(5)
2 Diagnosis and Treatment of Esophageal Chest Pain
18(20)
Edward C. Oldfield IV
Parth J. Parekh
David A. Johnson
Introduction
18(1)
Epidemiology
18(1)
Gastroesophageal reflux
19(2)
Pathophysiology
19(1)
Diagnosis and treatment
19(2)
Summary
21(1)
Esophageal hypersensitivity
21(6)
Pathophysiology
21(3)
Treatment
24(1)
Pharmacologic
24(1)
Non-pharmacologic
25(1)
Conclusion
27(1)
Dysmotility
27(2)
Achalasia
27(1)
Pathophysiology
27(1)
Distal esophageal spasm
28(1)
Pathophysiology
28(1)
Hypercontractile (jackhammer) esophagus
28(1)
Pathophysiology
28(1)
Available treatment options for esophageal chest pain
29(1)
Pharmacotherapy
29(1)
Endoscopic and surgical management
29(1)
Conclusion
30(1)
References
31(7)
3 Disorders Causing Oropharyngeal Dysphagia
38(15)
Patrick Sanvanson
Reza Shaker
Introduction
38(1)
Swallowing
39(4)
Mechanisms
39(2)
Control
41(1)
Sensory afferent pathways
41(1)
Central organizing center
41(1)
Motor efferent pathways
42(1)
Musculature
42(1)
Presentation
43(1)
Evaluation
44(2)
Physical examination
44(1)
Laboratory tests
44(1)
Dynamic studies
44(1)
Modified barium swallow
44(1)
Videoendoscopy
45(1)
Manometry
45(1)
Ultrasonography
46(1)
Management
46(3)
Endoscopic and surgical management
46(1)
Swallowing and postural techniques
47(1)
Swallowing maneuvers and exercises
47(1)
Postural techniques
48(1)
Cost-effectiveness
48(1)
Pharmacologic treatment
49(1)
Diet and lifestyle
49(1)
Conclusions
49(1)
References
49(4)
4 The Esophagus: Rumination Syndrome
53(6)
Magnus Holland
David A. Katzka
Introduction
53(1)
Definition, clinical presentation, and demographic characteristics
53(1)
Differential diagnosis
53(1)
Pathophysiology
54(1)
Diagnosis
55(1)
Treatment
55(2)
Diaphragmatic breathing
55(1)
Psychologic approaches
56(1)
Medical therapy
56(1)
Fundoplication
57(1)
Conclusion
57(1)
References
57(2)
Part II Esophageal Physiology and Testing 59(188)
5 Functional Anatomy and Physiology of Swallowing and Esophageal Motility
61(36)
Arvind Rengarajan
C. Prakash Gyawali
Introduction
61(1)
Swallowing
61(4)
Swallowing pattern generator
62(1)
Organizational structure and function
62(1)
Sensory
63(1)
Motor
63(1)
Organization
63(1)
Cortical and supramedullary influences
64(1)
Oropharyngeal stage motor activity
64(1)
Propulsion of the bolus
65(1)
Protection of the nasal cavity
65(1)
Protection of the airway
65(1)
Upper esophageal sphincter
65(5)
Anatomy and innervation
65(2)
Functional motor activity
67(1)
Basal pressures
67(1)
Swallowing
68(1)
Esophagopharyngeal reflexes
69(1)
Esophageal stage motor activity
70(8)
Esophageal body
70(1)
Anatomy, structure, and innervation
70(1)
Striated muscle
71(1)
Smooth muscle
71(1)
Functional motor activity
71(1)
Primary peristalsis
71(1)
Secondary peristalsis
72(1)
Tertiary peristalsis
73(1)
Afferent sensory stimulation
73(1)
Muscle tone
74(1)
Smooth muscle esophageal body: motor activity
74(1)
Central control mechanisms
74(1)
Intramural neural control mechanisms
75(1)
Intramural myogenic (muscle) control mechanisms
76(1)
Integration of central and peripheral mechanisms
77(1)
Deglutitive inhibition
77(1)
Lower esophageal sphincter
78(5)
Anatomy and innervation
78(1)
Phrenoesophageal membrane
78(1)
Diaphragm
78(1)
Intrinsic lower esophageal sphincter
78(2)
Functional motor activity
80(1)
Resting or basal pressure
80(1)
Transient lower esophageal sphincter relaxations
82(1)
Diaphragm
82(1)
References
83(14)
6 Radiology of the Pharynx and Esophagus
97(51)
Marc S. Levine
Stephen E. Rubesin
Introduction
97(1)
Pharynx
97(17)
Normal pharyngeal anatomy
97(2)
Normal oral and pharyngeal motility
99(2)
Neuromuscular disorders
101(2)
Pouches and diverticula
103(1)
Zenker's diverticula
103(1)
Killian-Jamieson diverticula and pouches
106(1)
Lateral pharyngeal pouches and diverticula
107(1)
Branchial pouch sinuses and branchial cleft fistulae
107(1)
Inflammatory conditions
108(1)
Lymphoid hyperplasia
108(1)
Pharyngeal and cervical esophageal webs
108(2)
Tumors
110(1)
Benign tumors and cysts
110(1)
Squamous cell carcinoma
110(1)
Lymphoma
113(1)
Radiation change
113(1)
Esophagus
114(29)
Technique
114(1)
Gastroesophageal reflux disease
115(1)
Reflux esophagitis
115(1)
Scarring and strictures
116(1)
Barrett's esophagus
117(4)
Infectious esophagitis
121(1)
Candida esophagitis
121(1)
Herpes esophagitis
122(1)
Cytomegalovirus esophagitis
123(1)
Human immunodeficiency virus esophagitis
123(1)
Drug-induced esophagitis
123(2)
Eosinophilic esophagitis
125(1)
Lichen planus
125(1)
Radiation esophagitis
126(1)
Caustic esophagitis
126(1)
Other esophagitides
127(1)
Benign tumors
128(1)
Papilloma
128(1)
Adenoma
128(1)
Glycogenic acanthosis
128(1)
Leiomyoma
129(1)
Fibrovascular polyp
129(1)
Duplication cyst
130(1)
Malignant tumors
131(1)
Esophageal carcinoma
131(1)
Other malignant tumors
134(1)
Lower esophageal rings
134(1)
Diverticula
135(1)
Pulsion diverticula
138(1)
Traction diverticula
138(1)
Esophageal intramural pseudodiverticula
138(1)
Esophageal motility disorders
139(1)
Achalasia
139(1)
Diffuse esophageal spasm
140(1)
Presbyesophagus
140(1)
Varices
140(1)
Foreign body impactions
141(1)
Fistulae
142(1)
Perforation
143(1)
References
143(5)
7 Special Endoscopic Imaging and Optical Techniques for Evaluating the Esophagus
148(7)
John A. Dumot
John J. Vargo
Arvind J. Trindade
Chromoendoscopy
149(1)
Electronic chromoendoscopy
149(1)
Confocal laser endomicroscopy (CLE)
149(4)
Volumetric laser endomicroscopy (VLE)
153(1)
Summary
153(1)
References
153(2)
8 High-Resolution Manometry and Esophageal Pressure Topography
155(17)
Dustin A. Carlson
Peter J. Kahrilas
Acknowledgments
155(1)
Introduction
155(1)
Indications for esophageal manometry
155(1)
Manometry study technique and protocol
155(2)
The HRM assembly
155(1)
Patient selection and preparation
156(1)
Manometry catheter placement
156(1)
Baseline evaluation
157(1)
Test swallows
157(1)
Interpretation of high-resolution manometry and esophageal pressure topography
157(6)
Step 1: Evaluate EGJ morphology and tone
158(1)
Step 2: Apply HRM metrics to individual swallows
159(1)
Step 3: Classify individual test swallows
160(1)
Step 4: Step designation of an esophageal motility diagnosis
161(2)
HRM/EPT beyond the Chicago classification
163(4)
Application of esophageal manometry to gastroesophageal reflux disease: The Lyon Consensus
163(1)
High-resolution impedance manometry (HRIM)
163(2)
Application of adjunctive or provocative maneuvers
165(2)
Conclusions
167(1)
References
167(5)
9 Esophageal Testing Using Multichannel Intraluminal Impedance
172(16)
Mohamed Khalaf
Amit Agrawal
Introduction
172(1)
Basic principles
172(1)
High-resolution impedance manometry
173(1)
Esophageal function testing using combined multichannel intraluminal impedance and manometry
173(1)
Multichannel intraluminal impedance for assessment of bolus transit in esophageal function tests
174(2)
Combined MII-EM in belching and rumination
176(2)
Combined multichannel intraluminal impedance and pH for detection of acid and nonacid gastroesophageal reflux
178(6)
MII-pH catheter characteristics and placement
180(1)
MII-pH interpretation
180(2)
Clinical applications
182(1)
Assessment of mucosal integrity using baseline impedance measured by MII-pH catheter
182(1)
Direct mucosal impedance measurement
183(1)
References
184(4)
10 Ambulatory Monitoring for Reflux
188(20)
Frank Zerbib
John E. Pandolfino
Introduction
188(1)
Esophageal pH monitoring
188(6)
Catheter-based pH monitoring
189(1)
Electrodes
189(1)
Practical aspects
189(1)
Interpretation: normal values
190(1)
Proximal pH Recordings
190(1)
Wireless pH monitoring
191(1)
Technical aspects
191(1)
Comparison between catheter and capsule
192(1)
Tolerability and complications
192(1)
Benefit of extended duration of recording
192(1)
Clinical relevance of esophageal pH monitoring
192(1)
pH monitoring off therapy
192(1)
pH monitoring on therapy
193(1)
Esophageal pH-impedance monitoring
194(4)
Technical aspects
194(1)
Interpretation
195(1)
Pharyngeal impedance
195(2)
Clinical relevance of esophageal pH-impedance monitoring
197(1)
Studies off therapy
197(1)
Studies on therapy
197(1)
Novel impedance metrics
197(1)
Esophageal bilirubin monitoring
198(1)
Technical aspects
198(1)
Clinical relevance of esophageal bilirubin monitoring
198(1)
Symptom association analysis
199(1)
GERD phenotypes
200(1)
Pathological GERD
200(1)
Reflux hypersensitivity
201(1)
Functional heartburn/chest pain or alternate diagnosis
201(1)
Borderline situations
201(1)
Clinical applications
201(2)
Typical symptoms
201(1)
Supraesophageal symptoms
202(1)
ENT symptoms
203(1)
References
203(5)
11 New Diagnostic Tests for GERD
208(10)
Robert T. Kavitt
Michael F. Vaezi
Introduction
208(1)
Bile monitoring
208(1)
Novel impedance parameters
209(1)
Salivary pepsin
210(1)
Mucosal integrity
211(1)
Oropharyngeal pH monitoring
212(2)
Narrow-band imaging
214(1)
The road ahead
214(1)
References
214(4)
12 Role of Histology and Cytology in Esophageal Diseases
218(29)
Xiuli Liu
John R. Goldblum
Introduction
218(1)
Normal esophagus
218(1)
Esophagitis
219(6)
Infectious esophagitis
220(1)
Candida esophagitis
220(1)
Herpes esophagitis
220(1)
Cytomegalovirus esophagitis
221(1)
Other types of infectious esophagitis
222(1)
Radiation- and chemotherapy-induced esophagitis
222(1)
Pill/drug-induced and corrosive esophagitis
223(1)
Pill/drug-related esophagitis
223(1)
Corrosive esophagitis
224(1)
Primary eosinophilic esophagitis
224(1)
Primary lymphocytic esophagitis
225(1)
Esophageal Involvement in Systemic Disease
225(1)
Eosinophilic gastroenteritis
225(1)
Crohn's disease
226(1)
Esophageal manifestations of dermatologic and collagen vascular diseases
226(2)
Bullous diseases
226(1)
Pemphigus vulgaris
226(1)
Bullous pemphigoid
226(1)
Lichen planus
226(1)
Collagen vascular diseases
227(1)
Scleroderma
227(1)
Graft-versus-host disease
227(1)
Gastroesophageal reflux esophagitis
228(2)
Barrett's esophagus
230(10)
Diagnosis in esophageal mucosal biopsy
230(2)
Barrett's esophagus-related dysplasia and neoplasm
232(1)
Diagnosis in esophageal mucosal biopsies
232(1)
Negative for dysplasia
232(1)
Indefinite for dysplasia
233(1)
Positive for dysplasia
233(1)
Intramucosal adenocarcinoma
234(1)
Adenocarcinoma with submucosal invasion
234(1)
Diagnostic challenges
235(1)
Evaluation of endoscopic mucosal resection and endoscopic submucosal dissection specimens
235(1)
Evaluation of esophageal mucosal biopsy following mucosal ablation therapy
235(1)
Evaluation of esophageal cytology specimens in BE and BE-related neoplasia
236(1)
Other carcinomas and malignancies
236(1)
Squamous cell carcinoma
236(1)
Small cell carcinoma
239(1)
Malignant melanoma
240(1)
References
240(7)
Part III Motility Disorders 247(86)
13 Achalasia
249(16)
Guy E. Boeckxstaens
Albert J. Bredenoord
Definition
249(1)
Epidemiology
249(1)
Pathophysiology
249(3)
Clinical manifestations
252(1)
Diagnosis
252(2)
Treatment
254(5)
Pharmacological treatment
254(1)
Smooth muscle relaxants
254(1)
Botulinum toxin A
254(1)
Pneumodilation
255(1)
Laparoscopic Heller myotomy
256(1)
Pneumodilation vs. laparoscopic Heller myotomy
257(1)
Per-oral endoscopic myotomy (POEM)
258(1)
What to do if symptoms reoccur following successful initial treatment
259(1)
Esophagectomy for end-stage achalasia
259(1)
Prognosis
259(1)
To screen or not for esophageal cancer?
260(1)
Guidelines
260(1)
References
261(4)
14 Non-Achalasia Esophageal Motility Abnormalities
265(13)
Steven Clayton
Introduction
265(1)
Disorders with esophagogastric junction outflow obstruction other than achalasia
265(2)
Esophagogastric junction outflow obstruction
265(2)
Major disorders of peristalsis
267(4)
Distal esophageal spasm
268(1)
Hypercontractile peristalsis (jackhammer esophagus)
269(1)
Treatment of distal esophageal spasm and jackhammer esophagus
270(1)
Minor disorders of peristalsis
271(2)
Ineffective esophageal motility
271(1)
Fragmented peristalsis
272(1)
Treatment of ineffective esophageal motility and fragmented peristalsis
272(1)
Conclusions and future directions
273(1)
References
274(4)
15 Surgery for Esophageal Motor Disorders: Achalasia, DES, Jackhammer, and EGJOO
278(16)
Brett Parker
Lee L. Swanstrom
Introduction
278(1)
Achalasia
278(9)
Endoscopic botulinum toxin injection
279(1)
Outcomes
279(1)
Endoscopic pneumatic dilatation
279(1)
Technique
280(1)
Outcomes
280(1)
Endoscopic stenting
280(1)
Per-oral endoscopic myotomy (POEM)
280(1)
POEM technique
281(1)
Mucosal incision
281(1)
Submucosal tunneling
281(1)
Myotomy
281(1)
Mucosal closure
282(1)
Outcomes
282(1)
POEM vs. pneumatic dilation
283(1)
Surgical esophageal myotomy
283(1)
Technique
283(1)
Outcomes
284(1)
Heller myotomy vs. POEM
285(1)
Heller myotomy vs. pneumatic dilation
286(1)
Minimally invasive esophagectomy
287(1)
Technique
287(1)
Esophagogastric junction outflow obstruction
287(1)
Distal esophageal spasm
288(1)
Jackhammer esophagus
289(1)
Conclusion
289(1)
References
290(4)
16 Esophageal Webs and Rings
294(10)
Mohamed Khalaf
Donald Castell
Definitions
294(1)
Proximal esophageal webs
294(2)
Prevalence and etiology
294(1)
Symptoms and diagnosis
295(1)
Treatment
295(1)
Plummer-Vinson syndrome
296(1)
Lower esophageal rings
297(1)
Schatzki's ring
298(2)
Epidemiology, pathology, and pathogenesis
298(1)
Presentation and diagnosis
298(1)
Treatment
299(1)
References
300(4)
17 Esophageal Diverticula
304(8)
Tara Barry
Adham R. Saad
Vic Velanovich
Classification
304(1)
Epidemiology
304(1)
Anatomy
304(1)
Proximal esophageal diverticula
304(1)
Mid-esophageal diverticula
304(1)
Lower esophageal diverticula (epiphrenic)
304(1)
Pathophysiology
305(1)
Symptoms
305(1)
Complications
306(1)
Physical examination
306(1)
Diagnostic studies
306(1)
Contrast esophagogram
306(1)
Esophagogastroduodenoscopy (EGD)
307(1)
Esophageal manometry
307(1)
Ultrasonography
307(1)
Surgical management
307(3)
Cricopharyngeal diverticulum
307(2)
Mid-esophageal diverticulum
309(1)
Epiphrenic diverticulum
309(1)
Post-operative management
310(1)
References
311(1)
18 Esophageal Involvement in Systemic Diseases
312(21)
John O. Clarke
Introduction
312(1)
Connective tissue disorders
312(6)
Systemic sclerosis (scleroderma)
312(4)
Mixed connective tissue disease
316(1)
Myositis
316(1)
Sjogren's syndrome
317(1)
Systemic lupus erythematosus
318(1)
Fibromyalgia
318(1)
Endocrine disorders
318(1)
Diabetes mellitus
318(1)
Thyroid disease
319(1)
Genetic syndromes
319(1)
Down syndrome
319(1)
Ehlers-Danlos syndrome
320(1)
Infiltrative disorders
320(2)
Amyloidosis
320(2)
Sarcoidosis
322(1)
Inflammatory disorders
322(2)
Crohn's disease
322(1)
Behcet's disease
323(1)
Mast cell disorders
323(1)
Neuromuscular disorders
324(1)
Myasthenia
324(1)
Paraneoplastic syndromes
324(1)
Parkinson's disease
325(1)
Conclusion
325(1)
References
325(8)
Part IV Gastroesophageal Reflux Disease 333(300)
19 Clinical Spectrum and Diagnosis of GERD Phenotypes
335(12)
Rena Yadlapati
Introduction
335(1)
The current paradigm of gastroesophageal reflux disease
335(1)
Definition and prevalence
335(1)
The era of proton pump inhibitor therapy
335(1)
Clinical spectrum of GERD
336(5)
Clinical history
336(1)
Esophageal syndromes of GERD
337(1)
Extraesophageal syndromes of GERD
337(1)
Clinical assessment for relevant comorbid conditions
338(1)
Clinical history: phenotypes
338(1)
Endoscopic evaluation
338(1)
Endoscopic assessment of esophageal mucosa
338(1)
Endoscopic assessment of the anti-reflux barrier
339(1)
Other roles of endoscopic assessment in GERD
339(1)
Upper gastrointestinal endoscopy: phenotypes
339(1)
Ambulatory reflux monitoring
339(1)
Ambulatory reflux monitoring systems
340(1)
Ambulatory reflux monitoring with or without acid suppression
340(1)
Ambulatory reflux monitoring metrics
340(1)
Correlation between symptoms and ambulatory reflux events
341(1)
Reflux hypersensitivity
341(1)
Ambulatory reflux monitoring: phenotypes
341(1)
Stepwise framework to phenotyping across the GERD spectrum
341(1)
Further esophageal physiologic testing
341(2)
Esophageal manometry
341(1)
Ambulatory reflux monitoring on acid suppression
342(1)
Conclusion
343(1)
References
343(4)
20 Hiatus Hernia and Gastroesophageal Reflux Disease
347(11)
Wout O.A. Rohof
Andre J.P.M. Smout
Introduction
347(1)
Anatomy of the diaphragm and the esophagogastric junction
347(1)
Physiology of the esophagogastric junction
348(1)
Hiatus hernia
349(1)
Type I hiatus hernia
349(1)
Type II and III hiatus hernias
350(1)
Type IV hiatal hernia
350(1)
Congenital diaphragmatic hernias
350(1)
Sliding hiatus hernia and reflux disease
350(2)
Diagnosis
352(1)
Therapy
353(1)
Conclusions
354(1)
References
354(4)
21 Pathophysiology of Gastroesophageal Reflux Disease: Motility Factors
358(18)
Ravinder K. Mittal
Sabine Roman
Introduction
358(1)
Sphincter mechanism at the esophagogastric junction (EGJ)
358(2)
Historical perspective
358(1)
Morphology of the sphincter mechanism at the esophagogastric Junction (EGJ)
358(2)
Gastroesophageal junction pressure under various physiologic conditions
360(3)
Circumferential and axial asymmetry of the EGJ pressure
361(1)
Neural control of the lower esophageal sphincter and crural diaphragm
362(1)
Physiologic significance of the two lower esophageal sphincters at the EGJ
363(1)
Mechanisms of gastroesophageal reflux
363(5)
Transient lower esophageal sphincter relaxation (TLESR)
363(1)
Characteristics of transient lower esophageal sphincter relaxation (TLESR)
364(1)
Stimuli that trigger transient lower esophageal sphincter relaxations
365(1)
Gastric distention
365(1)
Pharyngeal mechanisms
365(1)
Factors modulating the rate of transient lower esophageal sphincter relaxations
366(1)
Neural pathways mediating transient lower esophageal sphincter relaxation: vagal control mechanisms
366(1)
Effect of antireflux therapy on transient lower esophageal sphincter relaxation
368(1)
Lower esophageal sphincter hypotension in reflux disease
368(1)
Hiatus hernia and reflux disease
368(1)
Compliance/opening function of LES and EGJ in GER disease
369(1)
Role of esophageal peristalsis in reflux disease
370(1)
Conclusions
370(1)
References
371(5)
22 Pathophysiology of Gastroesophageal Reflux Disease: Epithelial Factors
376(18)
Shere Paris
Rhonda F. Souza
Introduction
376(1)
Acid, pepsin, and bile acids: the epithelial triple threat
376(1)
Development of the esophagus and its defensive players
377(1)
Esophageal tissue resistance: epithelial factors and beyond
378(4)
Pre-epithelial defense
378(1)
Epithelial defense
378(3)
Postepithelial defense
381(1)
Assessing the epithelial barrier: measurements of resistance, permeability, and intercellular spaces
382(1)
Pathophysiology of GERD and reflux esophagitis: acid burn or cytokine sizzle?
382(6)
Acid burn: the traditional concept
382(1)
Pathogenesis of GERD and acute reflux esophagitis: lessons from the rabbit model and GERD patients
382(2)
Cytokine sizzle: the alternative concept
384(1)
Pathogenesis of GERD and acute reflux esophagitis: lessons from the rat model and from GERD patients
384(1)
Pathogenesis of GERD and acute reflux esophagitis: lessons from the human model
385(1)
Hypoxia-inducible factor-2a: a key mediator of the cytokine sizzle in human reflux esophagitis
387(1)
Conclusions and future directions
388(1)
References
388(6)
23 Duodenogastroesophageal Reflux
394(25)
Daniel Sifrim
Roberto Penagini
Introduction
394(1)
The role of acid and pepsin
394(2)
Animal studies
394(1)
Human studies
395(1)
The role of duodenal contents
396(5)
Bile acids in the pathogenesis of Barrett's esophagus and/or esophageal adenocarcinoma
396(2)
In vitro
398(2)
Bile acids in the pathogenesis of erosive and non-erosive reflux disease
400(1)
Impact of DGER on laryngeal and respiratory mucosa
401(1)
Detection of DGER in humans
402(8)
Endoscopy
402(1)
Gastric measurements
402(1)
Gastric pH
402(1)
Gastric aspiration
403(1)
Esophageal aspiration
403(1)
Scintigraphy
403(1)
Ambulatory pH monitoring
404(1)
Ambulatory bilirubin monitoring (Bilitec)
405(3)
Impedance-pH monitoring
408(1)
DGER and symptoms
409(1)
DGER and bariatric surgery
410(1)
Medical and surgical treatment
410(2)
Conclusion
412(1)
References
413(6)
24 Helicobacter pylori and GERD
419(9)
Kristle Lee Lynch
Gaty W. Falk
Introduction
419(1)
Epidemiology of H. pylori and GERD
419(1)
Pathobiology of H. pylori and GERD
419(2)
Implication of eradication of H. pylori on de novo GERD
421(1)
Implication of H. pylori eradication on patients with known GERD
422(1)
H. pylori and Barrett's esophagus
422(1)
H. pylori and esophageal adenocarcinoma and gastroesophageal junction adenocarcinoma
422(1)
Professional guidelines, recommendations, and updates
423(1)
Conclusions
423(1)
References
424(4)
25 Medical Management of Gastroesophageal Reflux Disease
428(16)
Felice Schnoll-Sussman
Philip O. Katz
Introduction
428(1)
Lifestyle modifications
428(3)
Sleep
429(1)
Food and weight
430(1)
Alcohol
430(1)
Summary
430(1)
Pharmacologic therapy
431(5)
Antacids
431(1)
Sucralfate
431(1)
Promotility therapy
431(1)
Baclofen
432(1)
Acid-suppressive therapy
432(1)
Acid production
432(1)
H2-receptor antagonists
433(1)
Proton pump inhibitors (PPIs)
433(1)
Clinical efficacy
434(1)
pH control
434(1)
Symptom relief
434(1)
Healing of erosive esophagitis
434(1)
Optimizing PPI efficacy
434(2)
Long-term management
436(3)
Nocturnal GERD
436(1)
Side Effects of PPIs
437(2)
Newer antisecretory agents: potassium-competitive acid blockers
439(1)
References
439(5)
26 Refractory Heartburn: Reflux Hypersensitivity and Functional Heartburn
444(21)
Fahmi Shibli
Ronnie Fass
Introduction
444(1)
Functional heartburn
445(8)
Definition
445(1)
Epidemiology
446(1)
Pathophysiology
447(3)
Clinical presentation
450(1)
Diagnosis
450(1)
Treatment
451(2)
Reflux hypersensitivity
453(5)
Definition
454(1)
Epidemiology
454(1)
Pathophysiology
455(1)
Clinical presentation
456(1)
Diagnosis
456(1)
Treatment
457(1)
Overlap with GERD
458(1)
References
459(6)
27 Endoscopic Therapies for GERD
465(27)
Kenneth J. Chang
Introduction
465(1)
Understanding GEJ anatomy and physiology
466(1)
Radiofrequency energy treatment of GERD (Stretta)
467(7)
Stretta mechanisms of action
467(1)
Stretta patient selection
468(1)
Stretta in altered anatomy
468(1)
Stretta technical considerations
469(2)
Stretta safety and clinical outcomes
471(3)
Stretta summary
474(1)
Trans-oral incisionless fundoplication (TIF)
474(9)
TIF mechanisms of action
474(2)
TIF patient selection
476(1)
TIF technical considerations
476(3)
TIF safety and clinical outcomes
479(2)
Concomitant laparoscopic hernia repair and TIF
481(1)
Emerging applications for TIF
482(1)
TIF summary
483(1)
Endoscopic suturing for GERD
483(4)
Gastro-gastric plication mechanism of action
484(1)
Evolution of full-thickness endoscopic suturing for GERD
484(3)
Conclusions
487(1)
References
487(5)
28 Behavioral Treatment of Oropharyngeal and Esophageal Disorders
492(18)
Joy E. Gaziano
Dysphagia
492(6)
Swallow physiology
492(1)
Oropharyngeal swallow assessment
493(1)
Multiphase swallow assessment
493(2)
Dysphagia rehabilitation principles
495(1)
Indirect swallowing treatment
495(1)
Diet modifications
495(1)
Mealtime modifications
496(1)
Postural strategies
496(1)
Swallowing maneuvers
496(1)
Direct swallowing treatment
497(1)
Oral phase exercise
497(1)
Pharyngeal phase exercise
497(1)
Behavioral strategies for esophageal dysphagia
498(1)
Aerophagia
498(2)
Assessment of aerophagia
499(1)
Behavioral treatment of aerophagia
499(1)
Supragastric belching
500(1)
Assessment of supragastric belching
500(1)
Behavioral treatment of supragastric belching
500(1)
Plan of care for supragastric belching
500(1)
Rumination
501(1)
Assessment of rumination
501(1)
Behavioral treatment of rumination
501(1)
Plan of care for rumination
502(1)
Extraesophageal reflux
502(1)
Behavioral treatment
502(1)
EER and Swallowing
502(1)
EER and voice
502(1)
Disorders of laryngeal hyper-responsiveness
503(2)
Vocal cord dysfunction
503(1)
Plan of care for behavioral treatment of VCD
504(1)
Chronic cough
504(1)
Plan of care for behavioral treatment of chronic cough
505(1)
Summary
505(1)
References
505(5)
29 Barrett's Esophagus
510(22)
Puja Sukhwani Elias
Stuart Jon Spechler
Introduction
510(1)
Definition and diagnostic criteria
510(1)
Epidemiology
511(1)
Pathogenesis and progression
511(4)
Pathogenesis of metaplasia
511(2)
The neoplastic progression
513(1)
Dysplasia
514(1)
Clinical Presentation
515(1)
Clinical features
515(1)
Endoscopic diagnosis
515(1)
Management
516(3)
Screening for BE
516(1)
Surveillance for BE
516(1)
Advanced imaging techniques
517(1)
Chromoendoscopy
517(1)
Narrow-band imaging (electronic chromoendoscopy)
518(1)
Confocal laser endomicroscopy
518(1)
Additional enhanced imaging techniques
519(1)
Treatment
519(4)
Non-dysplastic Barrett's
519(1)
Medical therapy
519(1)
Surgical options
520(1)
Chemopreventive agents and the AspECT trial
520(1)
Treatment of dysplastic Barrett's esophagus
521(1)
Endoscopic eradication therapy
521(1)
Endoscopic mucosal resection
521(1)
Endoscopic submucosal dissection (ESD)
522(1)
Endoscopic ablative techniques
522(1)
Radiofrequency ablation
522(1)
Cryotherapy
523(1)
Argon plasma coagulation (APC)
523(1)
Challenges In Management
523(2)
Surveillance after EET
523(1)
Future directions
524(1)
References
525(7)
30 Esophageal Strictures
532(22)
Sajiv Sethi
Joel Richter
Classification of strictures
532(1)
Types of esophageal dilators
533(1)
Techniques of esophageal dilation
534(3)
Choosing the correct initial dilator size
534(1)
The rule of three
534(1)
Selection of dilators and need for fluoroscopy
535(1)
Timing of dilation
535(1)
Endpoint of dilation
535(1)
Other tips for esophageal dilation
536(1)
Complications of esophageal dilation
536(1)
Simple strictures
537(4)
Peptic strictures
537(1)
Schatzki rings
538(1)
Esophageal webs
539(1)
Cricopharyngeal bars
539(1)
Lichen planus
539(1)
Eosinophilic esophagitis
540(1)
Complex strictures
541(2)
Post-endoscopic therapy strictures
541(1)
Post-ablative strictures
541(1)
Post-operative strictures
542(1)
Radiation-induced strictures
543(1)
Caustic strictures
543(1)
Nasogastric tube strictures
544(1)
Refractory strictures
544(1)
Steroid injections
544(1)
Incisional therapy
545(1)
Temporary stents
545(1)
Mitomycin C
546(1)
Self dilation
547(1)
Conclusions
547(1)
References
548(6)
31 ENT Complaints in GERD
554(13)
C. Ambrose
Kenneth C. Fletcher
C. Gaelyn Garrett
Introduction
554(1)
Prevalence
555(1)
Pathophysiology
555(1)
Diagnosis
555(2)
Laryngoscopy
557(2)
Confirmatory testing for EER/LPR
559(2)
Endoscopy
561(1)
Management
561(1)
Surgical therapy
562(1)
Cost
563(1)
Conclusion
563(1)
References
563(4)
32 Pulmonary Complications of Gastroesophageal Reflux Disease
567(14)
Walter W. Chan
Introduction
567(1)
Pathophysiology
567(2)
Clinical presentations and evaluation
569(1)
Therapy
570(1)
Asthma and GERD
570(3)
PPI and asthma
571(1)
Reflux monitoring in asthma
571(1)
Antireflux surgery in asthma
572(1)
Pulmonary fibrosis and GERD
573(2)
Reflux monitoring in IPF
573(1)
Antireflux therapies in IPF
574(1)
GERD and lung transplant
575(2)
Reflux testing and lung transplantation
575(1)
Antireflux therapy in lung transplantation
576(1)
Conclusions
577(1)
References
577(4)
33 Pediatric Gastroesophageal Reflux Disease
581(10)
Rachel Rosen
Samuel Nurko
Gastroesophageal reflux
581(1)
Pathophysiology
581(1)
Epidemiology
581(1)
Complications
582(1)
Diagnostic evaluation
582(2)
Upper gastrointestinal radiography (UGI)
582(1)
Nuclear scintigraphy
582(1)
Reflux testing
583(1)
pH probes
583(1)
Multichannel intraluminal impedance with pH (pH-MH)
583(1)
Symptom association
583(1)
Upper endoscopy with biopsy of the esophagus
584(1)
Other diagnostic approaches
584(1)
Treatment
584(2)
Non-pharmacologic therapies
584(2)
Transpyloric feeds
586(1)
Pharmacologic therapy
586(1)
Acid suppression
586(1)
Motility medications
587(1)
Surgical Therapy
587(1)
Conclusion
588(1)
References
588(3)
34 Challenges in the Understanding and Application of Antireflux Surgery for GERD
591(11)
Steven R. DeMeester
Tom R. DeMeester
Historical overview
591(1)
Fundoplications
591(5)
Tailored fundoplication
592(1)
Post-fundoplication side effects
593(1)
Candidates for antireflux surgery
594(1)
Application of surgical therapy to patients with GERD
595(1)
Outcome with a fundoplication
595(1)
Longevity of antireflux surgery
596(1)
Antireflux surgery and Barrett's esophagus
597(1)
Impact of antireflux surgery on the development of intestinal metaplasia
597(1)
Impact of antireflux surgery on intestinal metaplasia already present prior to surgery
597(1)
Impact of antireflux surgery on low-grade dysplasia
598(1)
Impact of antireflux surgery on progression of Barrett's and development of esophageal adenocarcinoma
598(1)
Antireflux surgery in patients with Barrett's: word of caution
598(1)
Conclusions
598(1)
References
599(3)
35 New Surgical Treatments for GERD
602(22)
Reginald Bell
Introduction
602(1)
The importance of alternatives therapies
602(1)
Limitations of Nissen fundoplication
602(1)
Magnetic sphincter augmentation (MSA) of the lower esophageal sphincter
603(7)
MSA design
603(1)
Initial design considerations
603(1)
LES length as a reflux barrier
605(1)
Physiologic comparison to fundoplication
605(1)
Design safety considerations
605(1)
Initial surgical technique and results
605(1)
Evolution of technique
606(1)
The essential role of the crural diaphragmatic sphincter
606(1)
Crural repair and evolution of surgical technique
606(1)
Evolving concept of LINX sizing
607(1)
Current MSA technique with restoration of the crural sphincter
608(2)
Current approach to patient selection and perioperative management
610(1)
Patient selection and preoperative evaluation
610(1)
Surgical training expertise
611(1)
Perioperative management
611(1)
Clinical results
611(1)
Patient-reported outcomes
611(1)
Subjective outcomes
613(1)
Objective outcomes
613(1)
Reproducibility
614(1)
Comparison to PPIs
614(1)
Comparison to fundoplication
614(1)
Specific presenting symptoms
615(1)
Predictors of outcomes of MSA
616(1)
Device safety
616(1)
Foreign body reaction
616(1)
Allergic reaction
616(1)
Erosion
616(1)
Comparison to other implants
616(1)
Safety data on erosions
616(1)
Other device limitations and concerns
617(1)
Risks, side effects, and complications
618(1)
Perioperative risks
618(1)
Dysphagia
618(1)
Reoperation after MSA implantation
618(1)
Future directions
619(1)
Magnetic sphincter augmentation - conclusions
619(1)
Lower esophageal sphincter (LES) electrical neuromodulation therapy (LES-ENT)
619(1)
References
620(4)
36 Obesity and Gastroesophageal Reflux Disease
624(9)
Hashem B. El-Serag
Aaron P. Thrift
Introduction
624(1)
Obesity and GERD symptoms
625(1)
Obesity and GERD-related complications
625(1)
Mechanical and non-mechanical effects of obesity
626(2)
Mechanical effects of obesity on the gastroesophageal junction
626(2)
Non-mechanical effects of obesity
628(1)
Weight loss as GERD treatment
628(1)
References
629(4)
Part V Malignant Disease 633(46)
37 Tumors of the Esophagus
635(16)
Michael S. Smith
Charles J. Lightdale
Introduction
635(1)
Malignant esophageal cancers
635(7)
Epidemiology
635(1)
Pathogenesis
635(2)
Clinical presentation and diagnosis
637(1)
Staging of esophageal cancer
637(2)
Restaging after initial chemoradiotherapy
639(1)
Endoscopic treatment of esophageal cancer
640(1)
Palliation of unresectable esophageal cancer
641(1)
Other malignancies of the esophagus
642(1)
Conclusions
642(1)
Benign tumors of the esophagus
642(2)
Esophageal leiomyomas
642(1)
Granular cell tumors
643(1)
Papillomas
643(1)
Fibrovascular polyps
643(1)
Other benign esophageal lesions
644(1)
Conclusions
644(1)
References
644(7)
38 Endoscopic Treatment of Esophageal Cancer
651(10)
Prasad G. Iyer
Kenneth K. Wang
Rationale for the endoscopic treatment of esophageal cancer
651(1)
Methods used in the endoscopic treatment of esophageal carcinoma
652(4)
Ablation techniques
656(1)
Ablation of residual Barrett's esophagus after resection of focal adenocarcinoma lesions
656(1)
Endoscopic ablation of non-resectable EAC
656(1)
Adjuvant chemotherapy and radiation therapy
656(1)
Outcomes of endoscopic treatment of early esophageal cancer
656(2)
T1a (mucosal) adenocarcinoma
656(2)
T1b (submucosal) adenocarcinoma
658(1)
References
658(3)
39 Surgical Treatment for Esophageal Cancer
661(18)
Luigi Bonavina
Alberto Luporini
Introduction
661(1)
Diagnosis and screening
661(1)
Staging
661(2)
Evaluation of cT
663(1)
Evaluation of cN
663(1)
Evaluation of cM
663(1)
Preoperative assessment of physiological status
663(2)
Pulmonary function
664(1)
Cardiovascular function
665(1)
Liver function
665(1)
Preoperative composite risk score and nomograms
665(1)
Surgical therapy
665(4)
Resection of primary tumor
665(1)
Lymphadenectomy
666(1)
Reconstruction
666(1)
Surgical approach
667(1)
Perioperative care
667(1)
Morbidity and mortality
668(1)
Recurrence
669(1)
Quality of life
669(1)
Neo-adjuvant therapy
669(1)
Pragmatic therapeutic strategy
670(1)
Conclusions
671(1)
Acknowledgment
672(1)
References
672(7)
Part VI Miscellaneous 679
40 Eosinophilic Esophagitis
681(32)
Ikuo Hirano
Evan S. Dellon
Financial support
681(1)
Introduction
681(1)
Epidemiology
681(2)
Incidence and prevalence
682(1)
Risk factors
682(1)
Diagnosis
683(3)
Current diagnostic criteria and approach
684(1)
Disease activity measures
685(1)
Clinical features
686(4)
Barium esophagram
686(1)
Endoscopy
686(2)
Endoluminal ultrasonography
688(1)
Esophageal manometry
688(1)
Impedance planimetry
689(1)
Phenotypes
689(1)
Histology
690(1)
Pathogenesis
691(1)
Natural history
692(1)
Treatment
693(8)
Endpoints
693(1)
PPIs
694(1)
Diet therapy
695(1)
Swallowed topical corticosteroids
696(1)
Anti-IgE
697(1)
CRTH2 antagonist
697(1)
Anti-IL-5
698(1)
Anti-IL-13
698(1)
Anti-IL-4 receptor
699(1)
Miscellaneous
699(1)
Esophageal dilation
699(1)
Maintenance therapy
700(1)
Conclusion
701(1)
References
701(12)
41 Foreign Bodies
713(15)
Rene D. Gomez-Esquivel
Introduction
713(1)
Anatomical considerations
714(3)
Clinical presentation
717(1)
Diagnostic evaluation
718(1)
Management
719(2)
Preparing for endoscopy
719(1)
Sedation considerations
719(1)
Equipment
719(1)
Overtubes
720(1)
Food impactions
721(2)
Sharp or pointed objects
723(1)
Batteries
723(1)
Magnets
724(1)
Small, blunt, round objects
725(1)
Coins
725(1)
Other objects
725(1)
Dishwasher or laundry pods
725(1)
Narcotic packages
726(1)
Management of complications
726(1)
References
726(2)
42 Medication-Induced Esophageal, Injury
728(8)
David A. Katzka
Introduction
728(1)
Mechanisms
728(1)
Pathology
729(1)
Clinical features and diagnosis
729(1)
Prevention, treatment, and clinical course
729(1)
Specific medications
730(2)
Antibiotics
730(1)
Bisphosphonates
730(1)
NSAIDs
731(1)
Other medications commonly associated with pill-induced injury
731(1)
Chemotherapy-induced esophagitis
732(1)
References
732(4)
43 Esophagitis in the Immunocompromised Host
736(21)
James P. Callaway
C. Mel Wilcox
Introduction
736(1)
Epidemiology
736(1)
Predisposing factors
737(1)
General considerations
737(1)
Fungal infections
738(6)
Candida species
738(1)
Epidemiology
738(1)
Pathology
738(1)
Clinical manifestations
739(1)
Complications
739(1)
Diagnosis
739(1)
Treatment
740(1)
Prophylaxis
742(1)
Drug resistance
742(1)
Other fungi
743(1)
Epidemiology
743(1)
Pathology, clinical manifestations, and complications
743(1)
Diagnosis
743(1)
Treatment
743(1)
Viral infections
744(4)
Herpes simplex virus
744(1)
Epidemiology
744(1)
Pathology
744(1)
Clinical manifestations and complications
744(1)
Diagnosis
745(1)
Treatment
745(1)
Cytomegalovirus
745(1)
Epidemiology
745(1)
Pathology
745(1)
Clinical manifestations and complications
746(1)
Diagnosis
746(1)
Therapy
746(1)
Prophylaxis
747(1)
Other viruses
747(1)
Mycobacterial infections
748(1)
Epidemiology
748(1)
Pathology
748(1)
Clinical manifestations and complications
748(1)
Diagnosis
748(1)
Treatment
748(1)
Bacterial infections
748(1)
Epidemiology
748(1)
Pathology
749(1)
Clinical manifestations and complications
749(1)
Diagnosis
749(1)
Treatment
749(1)
Treponema pallidum
749(1)
Protozoal infections
749(1)
Selected HIV-related esophageal disorders
749(2)
Disorders associated with primary HIV- infection
750(1)
Idiopathic esophageal ulcer
750(1)
Epidemiology
750(1)
Pathology
750(1)
Clinical manifestations and complications
750(1)
Diagnosis
750(1)
Treatment
750(1)
References
751(6)
44 Caustic Injuries of the Esophagus
757(12)
Dhyanesh Patel
Introduction
757(1)
Incidence
757(1)
Pathophysiology
757(1)
Alkali-induced injury
757(1)
Acid-induced injury
758(1)
Determinants of severity
759(1)
Risks of specific substances
759(1)
Clinical presentation
759(1)
Initial evaluation
760(2)
Endoscopy
760(1)
Computed tomography
760(2)
Management
762(1)
Stabilization and supportive care
762(1)
No role for emetics, neutralizing agents, or corticosteroids
762(1)
Nutrition
762(1)
Surgery
763(1)
Management of late complications
763(1)
Esophageal stricture
763(1)
Intralesional steroid injection
763(1)
Mitomycin-C injection
764(1)
Esophageal stent
764(1)
Esophageal cancer
764(1)
Conclusion
764(1)
References
764(5)
45 Rupture and Perforation of the Esophagus
769(20)
Phillip S. Ge
Gottumukkala S. Raju
Introduction
769(1)
Pathophysiology
769(1)
Boerhaave syndrome
769(2)
Esophageal obstruction
771(1)
Ingestions
771(1)
Trauma
772(1)
Iatrogenic perforation
772(1)
Clinical features and diagnosis
773(1)
Clinical presentation
773(1)
Diagnosis
773(1)
Approach to management
774(1)
Surgical management
774(1)
Endoscopic management
775(1)
Stent placement
776(7)
Endoscopic clips
777(3)
Endoscopic suturing
780(1)
Alternative endoscopic methods
781(2)
Prognosis
783(1)
Summary
783(1)
References
783(6)
46 Cutaneous Diseases of the Esophagus
789(15)
Michael J. Camilleri
Introduction
789(1)
Inflammatory mucocutaneous disorders of the skin and mucous membranes including the esophagus
789(7)
Autoimmune mucocutaneous blistering disorders
789(1)
Mucous membrane pemphigoid
789(1)
Epidermolysis bullosa acquisita
791(1)
Bullous systemic lupus erythematosus
792(1)
Pemphigus vulgaris
792(1)
Paraneoplastic autoimmune multiorgan syndrome (paraneoplastic pemphigus)
793(1)
Lichen planus
793(1)
Stevens Johnson syndrome and toxic epidermal necrolysis
795(1)
Multisystem disorders that have both mucocutaneous and esophageal manifestations
796(3)
Autoimmune connective tissue disorders
796(1)
Systemic sclerosis
796(1)
Dermatomyositis
797(1)
Systemic lupus erythematosus
797(1)
Mixed connective tissue disease
797(1)
Behcet's disease
798(1)
Cutaneous paraneoplastic disorders associated with esophageal carcinoma
798(1)
Bazex syndrome
798(1)
Tylosis with esophageal cancer
798(1)
Plummer-Vinson-Patterson-Kelly syndrome
798(1)
Dyskeratosis congenita
798(1)
Other cutaneous paraneoplastic disorders
798(1)
Genodermatoses with esophageal manifestations
799(1)
References
799(5)
47 Esophageal Disease in Older Patients
804
Kenneth R. DeVault
Sami R. Achem
Introduction
804(1)
Changes in esophageal physiology with aging
805(4)
Motility
805(1)
Upper esophageal sphincter/pharynx
805(1)
Esophageal body
805(1)
Lower esophageal sphincter
806(2)
Sensory function
808(1)
Gastroesophageal reflux disease in older patients
808(1)
Changes in gastroesophageal reflux disease-related physiology with aging
809(2)
Role of Helicobacter pylori infection and other gastric factors
809(1)
Obesity and aging
810(1)
Differences in presentation
810(1)
Cardiopulmonary concerns
810(1)
Special considerations related to Barrett's esophagus in older patients
810(1)
Differences in treatment of older patients
811(2)
Lifestyle and patient-directed therapy
811(1)
Medical therapy
811(2)
Surgery
813(1)
Dysphagia
813(1)
Prevalence and importance
813(1)
Oropharyngeal dysphagia
813(1)
Central nervous system diseases
814(7)
Stroke
814(2)
Alzheimer's disease
816(1)
Parkinson's disease
816(2)
Multiple sclerosis
818(1)
Thyroid disease
819(1)
Other neuromuscular disorders
819(1)
Myasthenia gravis
820(1)
Amyotrophic lateral sclerosis
821(1)
Idiopathic upper esophageal sphincter dysfunction
821(15)
Local structural lesions
822(1)
Zenker's diverticulum
822(2)
General approach to oropharyngeal dysphagia
824(1)
Esophageal dysphagia
825(1)
Achalasia
826(2)
Distal esophageal spasm and related disorders
828(1)
Esophagogastric junction outflow obstruction (EGJO)
829(1)
Jackhammer esophagus
830(1)
Scleroderma
830(2)
Esophageal cancer
832(1)
Peptic stricture
832(1)
Rings and webs
833(1)
Vascular compression
834(1)
Medication-induced esophageal injury
835(1)
Miscellaneous conditions
836(1)
Conclusions
836(1)
References
837
Index 85
Editors-in-Chief

Joel E. Richter MD, FACP, MACG is Hugh F. Culverhouse Chair of Esophagology at the University of South Florida Morsani College of Medicine. Tampa, Florida USA

The late Donald O. Castell MD was Professor Emeritus of Medicine at the Medical University of South Carolina, Charleston, SC, USA